SELLAS Life Sciences Group, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SLS Nasdaq 2836 sellaslifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for SELLAS Life Sciences Group, Inc.

SLS CEO Angelos Stergiou Highlights Extended Capital Runway To Pursue Key Milestones, Growth Opportunities – A Look At The Important Numbers - Jun 2nd, 2026 8:54 am
Jim Cramer on SELLAS: “It’s a Great Spec” - Jun 1st, 2026 11:33 am
SELLAS Life Sciences Group (SLS) Is Up 21.4% After REGAL Nears Topline Readout And Cramer Endorsement - May 29th, 2026 2:02 pm
SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout - May 28th, 2026 10:40 pm
SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS - May 27th, 2026 9:30 pm
SLS Stock Surges Toward Fifth Weekly Rise: CEO Touts GPS As Lifeline For Elderly Patients As Cancer Summit Looms - May 26th, 2026 9:21 pm
SLS Stock Heads For Its Best Month This Year Ahead Of Key AML Trial Readout - May 26th, 2026 5:26 am
SLS Stock Tanks Hard: Retail Traders Blame Warrant Holders, 'Flippers' Cashing Out Before AML Catalyst - May 21st, 2026 9:54 pm
SLS Stock Hits Over 4-Year High: CEO Eyes FDA Talks, ‘Whole Gamut’ Of Cancer Uses For GPS - May 21st, 2026 1:02 am
Why Did ARM, SLS, EBAY Stocks Surge To 52-Week Highs? - May 20th, 2026 10:46 pm
SELLAS Life Sciences (SLS) Is Up 50.5% After Pivotal AML Trial Nears Readout And Adds Funding Flexibility – Has The Bull Case Changed? - May 15th, 2026 1:14 pm
SELLAS Life Sciences to Participate in Upcoming Investor Conferences - May 14th, 2026 6:00 am
High Growth Tech Stocks in US for May 2026 - May 14th, 2026 5:38 am
SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses - May 13th, 2026 8:18 am
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - May 13th, 2026 6:06 am
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 12th, 2026 2:05 pm
Inventiva Builds Up Leadership Team Ahead of Potential Commercialization - Apr 22nd, 2026 4:03 pm
Wall Street Analysts Think SELLAS Life Sciences Group, Inc. (SLS) Could Surge 66.09%: Read This Before Placing a Bet - Apr 20th, 2026 7:55 am
SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment - Apr 14th, 2026 3:55 am
Solaris Secures EIA Technical Approval and Further Strengthens the Balance Sheet - Apr 9th, 2026 12:00 pm